nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A4—Temozolomide—melanoma	0.198	0.285	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.127	0.183	CbGbCtD
Finasteride—CYP3A7—Docetaxel—melanoma	0.127	0.183	CbGbCtD
Finasteride—CYP3A4—Vemurafenib—melanoma	0.109	0.156	CbGbCtD
Finasteride—CYP3A5—Docetaxel—melanoma	0.0955	0.138	CbGbCtD
Finasteride—CYP3A4—Docetaxel—melanoma	0.0372	0.0537	CbGbCtD
Finasteride—Trauma—Bleomycin—melanoma	0.00675	0.0566	CcSEcCtD
Finasteride—Neoplasm malignant—Vemurafenib—melanoma	0.00621	0.0521	CcSEcCtD
Finasteride—Breast cancer—Docetaxel—melanoma	0.00494	0.0414	CcSEcCtD
Finasteride—Neoplasm—Vemurafenib—melanoma	0.0048	0.0402	CcSEcCtD
Finasteride—Testosterone Propionate—CYP17A1—melanoma	0.00404	0.426	CrCbGaD
Finasteride—Tenderness—Bleomycin—melanoma	0.00369	0.0309	CcSEcCtD
Finasteride—Oedema peripheral—Vemurafenib—melanoma	0.00263	0.022	CcSEcCtD
Finasteride—Injury—Bleomycin—melanoma	0.00254	0.0213	CcSEcCtD
Finasteride—Neoplasm—Carmustine—melanoma	0.00254	0.0213	CcSEcCtD
Finasteride—Gynaecomastia—Carmustine—melanoma	0.00251	0.021	CcSEcCtD
Finasteride—Neoplasm—Temozolomide—melanoma	0.00245	0.0206	CcSEcCtD
Finasteride—Swelling—Carmustine—melanoma	0.00231	0.0194	CcSEcCtD
Finasteride—Injury—Carmustine—melanoma	0.00222	0.0186	CcSEcCtD
Finasteride—Infection—Vemurafenib—melanoma	0.00188	0.0158	CcSEcCtD
Finasteride—Progesterone—CYP17A1—melanoma	0.00186	0.196	CrCbGaD
Finasteride—Breast disorder—Temozolomide—melanoma	0.00178	0.0149	CcSEcCtD
Finasteride—Hypotension—Vemurafenib—melanoma	0.00177	0.0148	CcSEcCtD
Finasteride—Bronchitis—Temozolomide—melanoma	0.00164	0.0137	CcSEcCtD
Finasteride—Neoplasm—Docetaxel—melanoma	0.00163	0.0137	CcSEcCtD
Finasteride—Erectile dysfunction—Temozolomide—melanoma	0.00157	0.0131	CcSEcCtD
Finasteride—Pharyngitis—Dactinomycin—melanoma	0.00149	0.0125	CcSEcCtD
Finasteride—Swelling—Docetaxel—melanoma	0.00148	0.0124	CcSEcCtD
Finasteride—Sinusitis—Temozolomide—melanoma	0.00142	0.0119	CcSEcCtD
Finasteride—Hypersensitivity—Vemurafenib—melanoma	0.00139	0.0117	CcSEcCtD
Finasteride—Oedema peripheral—Carmustine—melanoma	0.00139	0.0116	CcSEcCtD
Finasteride—Asthenia—Vemurafenib—melanoma	0.00136	0.0114	CcSEcCtD
Finasteride—Pharyngitis—Temozolomide—melanoma	0.00135	0.0113	CcSEcCtD
Finasteride—Oedema peripheral—Temozolomide—melanoma	0.00134	0.0112	CcSEcCtD
Finasteride—Pruritus—Vemurafenib—melanoma	0.00134	0.0112	CcSEcCtD
Finasteride—Progesterone—CYP1B1—melanoma	0.00129	0.136	CrCbGaD
Finasteride—Dizziness—Vemurafenib—melanoma	0.00125	0.0105	CcSEcCtD
Finasteride—Mental disorder—Carmustine—melanoma	0.00123	0.0103	CcSEcCtD
Finasteride—Immune system disorder—Temozolomide—melanoma	0.00123	0.0103	CcSEcCtD
Finasteride—Testosterone—CYP1B1—melanoma	0.00122	0.128	CrCbGaD
Finasteride—Orthostatic hypotension—Docetaxel—melanoma	0.0012	0.01	CcSEcCtD
Finasteride—Rash—Vemurafenib—melanoma	0.00119	0.01	CcSEcCtD
Finasteride—Mental disorder—Temozolomide—melanoma	0.00119	0.01	CcSEcCtD
Finasteride—Dermatitis—Vemurafenib—melanoma	0.00119	0.01	CcSEcCtD
Finasteride—Headache—Vemurafenib—melanoma	0.00119	0.00994	CcSEcCtD
Finasteride—Breast disorder—Docetaxel—melanoma	0.00118	0.00992	CcSEcCtD
Finasteride—Infection—Bleomycin—melanoma	0.00114	0.00955	CcSEcCtD
Finasteride—Angioedema—Temozolomide—melanoma	0.00108	0.00908	CcSEcCtD
Finasteride—Hypotension—Bleomycin—melanoma	0.00107	0.00898	CcSEcCtD
Finasteride—Infection—Dactinomycin—melanoma	0.00106	0.00891	CcSEcCtD
Finasteride—Dyspnoea—Bleomycin—melanoma	0.00102	0.00857	CcSEcCtD
Finasteride—Infection—Carmustine—melanoma	0.000995	0.00834	CcSEcCtD
Finasteride—Pain—Bleomycin—melanoma	0.000981	0.00822	CcSEcCtD
Finasteride—Infection—Temozolomide—melanoma	0.000961	0.00806	CcSEcCtD
Finasteride—Hypotension—Carmustine—melanoma	0.000936	0.00784	CcSEcCtD
Finasteride—Pain—Dactinomycin—melanoma	0.000915	0.00767	CcSEcCtD
Finasteride—Urticaria—Bleomycin—melanoma	0.000911	0.00764	CcSEcCtD
Finasteride—Rhinitis—Docetaxel—melanoma	0.000908	0.00761	CcSEcCtD
Finasteride—Pharyngitis—Docetaxel—melanoma	0.000899	0.00753	CcSEcCtD
Finasteride—Dyspnoea—Carmustine—melanoma	0.000893	0.00748	CcSEcCtD
Finasteride—Oedema peripheral—Docetaxel—melanoma	0.000892	0.00748	CcSEcCtD
Finasteride—Somnolence—Carmustine—melanoma	0.00089	0.00746	CcSEcCtD
Finasteride—Dyspnoea—Temozolomide—melanoma	0.000863	0.00723	CcSEcCtD
Finasteride—Somnolence—Temozolomide—melanoma	0.00086	0.00721	CcSEcCtD
Finasteride—Pain—Carmustine—melanoma	0.000856	0.00718	CcSEcCtD
Finasteride—Hypersensitivity—Bleomycin—melanoma	0.000845	0.00708	CcSEcCtD
Finasteride—Pain—Temozolomide—melanoma	0.000827	0.00694	CcSEcCtD
Finasteride—Asthenia—Bleomycin—melanoma	0.000823	0.0069	CcSEcCtD
Finasteride—Immune system disorder—Docetaxel—melanoma	0.000818	0.00686	CcSEcCtD
Finasteride—Pruritus—Bleomycin—melanoma	0.000812	0.0068	CcSEcCtD
Finasteride—Mental disorder—Docetaxel—melanoma	0.000794	0.00665	CcSEcCtD
Finasteride—Hypersensitivity—Dactinomycin—melanoma	0.000788	0.00661	CcSEcCtD
Finasteride—Urticaria—Temozolomide—melanoma	0.000769	0.00644	CcSEcCtD
Finasteride—Asthenia—Dactinomycin—melanoma	0.000768	0.00643	CcSEcCtD
Finasteride—Hypersensitivity—Carmustine—melanoma	0.000738	0.00618	CcSEcCtD
Finasteride—Rash—Bleomycin—melanoma	0.000723	0.00606	CcSEcCtD
Finasteride—Dermatitis—Bleomycin—melanoma	0.000723	0.00606	CcSEcCtD
Finasteride—Asthenia—Carmustine—melanoma	0.000718	0.00602	CcSEcCtD
Finasteride—Hypersensitivity—Temozolomide—melanoma	0.000713	0.00598	CcSEcCtD
Finasteride—Asthenia—Temozolomide—melanoma	0.000694	0.00582	CcSEcCtD
Finasteride—Pruritus—Temozolomide—melanoma	0.000685	0.00574	CcSEcCtD
Finasteride—Rash—Dactinomycin—melanoma	0.000675	0.00565	CcSEcCtD
Finasteride—Dizziness—Carmustine—melanoma	0.000662	0.00555	CcSEcCtD
Finasteride—Dizziness—Temozolomide—melanoma	0.00064	0.00536	CcSEcCtD
Finasteride—Infection—Docetaxel—melanoma	0.000639	0.00536	CcSEcCtD
Finasteride—Rash—Carmustine—melanoma	0.000631	0.00529	CcSEcCtD
Finasteride—Dermatitis—Carmustine—melanoma	0.000631	0.00529	CcSEcCtD
Finasteride—Headache—Carmustine—melanoma	0.000627	0.00526	CcSEcCtD
Finasteride—Rash—Temozolomide—melanoma	0.00061	0.00511	CcSEcCtD
Finasteride—Dermatitis—Temozolomide—melanoma	0.00061	0.00511	CcSEcCtD
Finasteride—Headache—Temozolomide—melanoma	0.000606	0.00508	CcSEcCtD
Finasteride—Hypotension—Docetaxel—melanoma	0.000601	0.00504	CcSEcCtD
Finasteride—Dyspnoea—Docetaxel—melanoma	0.000574	0.00481	CcSEcCtD
Finasteride—Somnolence—Docetaxel—melanoma	0.000572	0.00479	CcSEcCtD
Finasteride—Pain—Docetaxel—melanoma	0.00055	0.00461	CcSEcCtD
Finasteride—SRD5A1—Metabolism—HPSE—melanoma	0.000521	0.00294	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000519	0.00293	CbGpPWpGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000517	0.00292	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CUBN—melanoma	0.000511	0.00288	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CUBN—melanoma	0.000511	0.00288	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000504	0.00284	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000503	0.00284	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—BSG—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CSPG4—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SDHD—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SDHD—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CSPG4—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—BSG—melanoma	0.000494	0.00279	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00048	0.00271	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GPAM—melanoma	0.000478	0.0027	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GPAM—melanoma	0.000478	0.0027	CbGpPWpGaD
Finasteride—Hypersensitivity—Docetaxel—melanoma	0.000474	0.00397	CcSEcCtD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000474	0.00267	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—LUM—melanoma	0.000473	0.00267	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PHGDH—melanoma	0.000473	0.00267	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—AKR1B10—melanoma	0.000468	0.00264	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HPSE—melanoma	0.000464	0.00262	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000462	0.00261	CbGpPWpGaD
Finasteride—Asthenia—Docetaxel—melanoma	0.000462	0.00387	CcSEcCtD
Finasteride—AKR1D1—Metabolism—CUBN—melanoma	0.000456	0.00257	CbGpPWpGaD
Finasteride—Pruritus—Docetaxel—melanoma	0.000455	0.00382	CcSEcCtD
Finasteride—AKR1D1—Metabolism—SDHD—melanoma	0.00044	0.00248	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CSPG4—melanoma	0.00044	0.00248	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—BSG—melanoma	0.00044	0.00248	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GPAM—melanoma	0.000426	0.0024	CbGpPWpGaD
Finasteride—Dizziness—Docetaxel—melanoma	0.000426	0.00357	CcSEcCtD
Finasteride—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000424	0.00239	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PLA2G6—melanoma	0.000406	0.00229	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PLA2G6—melanoma	0.000406	0.00229	CbGpPWpGaD
Finasteride—Rash—Docetaxel—melanoma	0.000406	0.0034	CcSEcCtD
Finasteride—Dermatitis—Docetaxel—melanoma	0.000405	0.0034	CcSEcCtD
Finasteride—Headache—Docetaxel—melanoma	0.000403	0.00338	CcSEcCtD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000389	0.0022	CbGpPWpGaD
Finasteride—Progesterone—ABCB1—melanoma	0.000369	0.0389	CrCbGaD
Finasteride—Testosterone—ALB—melanoma	0.000366	0.0386	CrCbGaD
Finasteride—SRD5A2—Metabolism—VCAN—melanoma	0.000365	0.00206	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—VCAN—melanoma	0.000365	0.00206	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PLA2G6—melanoma	0.000362	0.00204	CbGpPWpGaD
Finasteride—Testosterone—ABCB1—melanoma	0.000349	0.0368	CrCbGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000346	0.00195	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000346	0.00195	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000343	0.00193	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP17A1—melanoma	0.00034	0.00192	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP17A1—melanoma	0.000335	0.00189	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000334	0.00188	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000334	0.00188	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—VCAN—melanoma	0.000325	0.00184	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP17A1—melanoma	0.000308	0.00174	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP17A1—melanoma	0.000308	0.00174	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000308	0.00174	CbGpPWpGaD
Finasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000304	0.00171	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000304	0.00171	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000304	0.00171	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.0003	0.00169	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—ALB—melanoma	0.0003	0.00169	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000297	0.00168	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GNA11—melanoma	0.000291	0.00164	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GNA11—melanoma	0.000291	0.00164	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000289	0.00163	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000289	0.00163	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP1B1—melanoma	0.000286	0.00161	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—FASN—melanoma	0.000285	0.00161	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—FASN—melanoma	0.000285	0.00161	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP1B1—melanoma	0.000282	0.00159	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC5A5—melanoma	0.00028	0.00158	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC5A5—melanoma	0.00028	0.00158	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000276	0.00156	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP17A1—melanoma	0.000275	0.00155	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000271	0.00153	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GNAQ—melanoma	0.00027	0.00153	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GNAQ—melanoma	0.00027	0.00153	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CD44—melanoma	0.00027	0.00153	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CD44—melanoma	0.00027	0.00153	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000267	0.00151	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000265	0.0015	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000265	0.00149	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000265	0.00149	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000262	0.00148	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000262	0.00148	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000262	0.00148	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP1B1—melanoma	0.000259	0.00146	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GNA11—melanoma	0.000259	0.00146	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP1B1—melanoma	0.000259	0.00146	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—FASN—melanoma	0.000254	0.00143	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC5A5—melanoma	0.00025	0.00141	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP17A1—melanoma	0.000246	0.00139	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP17A1—melanoma	0.000242	0.00137	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GNAQ—melanoma	0.000241	0.00136	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CD44—melanoma	0.000241	0.00136	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000236	0.00133	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000234	0.00132	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP1B1—melanoma	0.000231	0.0013	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000229	0.00129	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000229	0.00129	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000223	0.00126	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00022	0.00124	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000218	0.00123	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000215	0.00121	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ABCB1—melanoma	0.000214	0.0012	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ABCB1—melanoma	0.000214	0.0012	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP1B1—melanoma	0.000207	0.00117	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000204	0.00115	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP1B1—melanoma	0.000204	0.00115	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000201	0.00114	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PRKCA—melanoma	0.000197	0.00111	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PRKCA—melanoma	0.000197	0.00111	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ERCC2—melanoma	0.000195	0.0011	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ERCC2—melanoma	0.000195	0.0011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACER3—melanoma	0.000191	0.00108	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ABCB1—melanoma	0.00019	0.00107	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000181	0.00102	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PRKCA—melanoma	0.000175	0.000988	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—UGT2B10—melanoma	0.000174	0.000984	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ERCC2—melanoma	0.000174	0.00098	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HS3ST5—melanoma	0.000162	0.000914	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000161	0.000911	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000161	0.000911	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CG—melanoma	0.000154	0.000868	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CG—melanoma	0.000154	0.000868	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PPARG—melanoma	0.000149	0.000838	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PPARG—melanoma	0.000149	0.000838	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000144	0.000812	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACER3—melanoma	0.000138	0.000777	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CG—melanoma	0.000137	0.000774	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CD—melanoma	0.000135	0.000763	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CD—melanoma	0.000135	0.000763	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ALB—melanoma	0.000134	0.000754	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ALB—melanoma	0.000134	0.000754	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PPARG—melanoma	0.000132	0.000747	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000129	0.000728	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—UGT2B10—melanoma	0.000126	0.000711	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLCB4—melanoma	0.000123	0.000693	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CD—melanoma	0.000121	0.00068	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALB—melanoma	0.000119	0.000672	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CB—melanoma	0.000118	0.000665	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CB—melanoma	0.000118	0.000665	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HS3ST5—melanoma	0.000117	0.000661	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS2—melanoma	0.000117	0.000659	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS2—melanoma	0.000117	0.000659	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC6A11—melanoma	0.000115	0.000652	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIP4K2A—melanoma	0.000115	0.000652	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000114	0.000644	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000113	0.000635	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTAP—melanoma	0.000112	0.000634	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CB—melanoma	0.000105	0.000593	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS2—melanoma	0.000104	0.000588	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTEN—melanoma	0.000102	0.000575	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTEN—melanoma	0.000102	0.000575	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PHGDH—melanoma	0.0001	0.000565	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LUM—melanoma	0.0001	0.000565	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HPSE—melanoma	9.82e-05	0.000554	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CUBN—melanoma	9.64e-05	0.000544	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1B1—melanoma	9.61e-05	0.000542	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	9.48e-05	0.000535	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CSPG4—melanoma	9.31e-05	0.000525	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—BSG—melanoma	9.31e-05	0.000525	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SDHD—melanoma	9.31e-05	0.000525	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTEN—melanoma	9.08e-05	0.000513	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPAM—melanoma	9.02e-05	0.000509	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLCB4—melanoma	8.88e-05	0.000501	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC6A11—melanoma	8.35e-05	0.000471	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIP4K2A—melanoma	8.35e-05	0.000471	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTAP—melanoma	8.12e-05	0.000458	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLA2G6—melanoma	7.67e-05	0.000433	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PHGDH—melanoma	7.24e-05	0.000408	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LUM—melanoma	7.24e-05	0.000408	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3CA—melanoma	7.19e-05	0.000406	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3CA—melanoma	7.19e-05	0.000406	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HPSE—melanoma	7.1e-05	0.0004	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CUBN—melanoma	6.97e-05	0.000393	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—VCAN—melanoma	6.89e-05	0.000389	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CSPG4—melanoma	6.73e-05	0.00038	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SDHD—melanoma	6.73e-05	0.00038	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—BSG—melanoma	6.73e-05	0.00038	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPAM—melanoma	6.52e-05	0.000368	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3CA—melanoma	6.41e-05	0.000362	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACER3—melanoma	6.41e-05	0.000361	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKT1—melanoma	5.87e-05	0.000331	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKT1—melanoma	5.87e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—UGT2B10—melanoma	5.86e-05	0.000331	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP17A1—melanoma	5.81e-05	0.000328	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLA2G6—melanoma	5.54e-05	0.000313	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GNA11—melanoma	5.49e-05	0.00031	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HS3ST5—melanoma	5.45e-05	0.000307	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FASN—melanoma	5.37e-05	0.000303	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC5A5—melanoma	5.28e-05	0.000298	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKT1—melanoma	5.23e-05	0.000295	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CD44—melanoma	5.1e-05	0.000288	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GNAQ—melanoma	5.1e-05	0.000288	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—VCAN—melanoma	4.98e-05	0.000281	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1B1—melanoma	4.89e-05	0.000276	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP17A1—melanoma	4.2e-05	0.000237	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLCB4—melanoma	4.13e-05	0.000233	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCB1—melanoma	4.03e-05	0.000227	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GNA11—melanoma	3.97e-05	0.000224	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIP4K2A—melanoma	3.88e-05	0.000219	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC6A11—melanoma	3.88e-05	0.000219	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FASN—melanoma	3.88e-05	0.000219	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A5—melanoma	3.82e-05	0.000215	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTAP—melanoma	3.78e-05	0.000213	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PRKCA—melanoma	3.71e-05	0.000209	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GNAQ—melanoma	3.69e-05	0.000208	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CD44—melanoma	3.69e-05	0.000208	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ERCC2—melanoma	3.68e-05	0.000207	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1B1—melanoma	3.53e-05	0.000199	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LUM—melanoma	3.36e-05	0.00019	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PHGDH—melanoma	3.36e-05	0.00019	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HPSE—melanoma	3.3e-05	0.000186	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CUBN—melanoma	3.24e-05	0.000183	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—BSG—melanoma	3.13e-05	0.000177	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SDHD—melanoma	3.13e-05	0.000177	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CSPG4—melanoma	3.13e-05	0.000177	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPAM—melanoma	3.03e-05	0.000171	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCB1—melanoma	2.91e-05	0.000164	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CG—melanoma	2.9e-05	0.000164	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPARG—melanoma	2.8e-05	0.000158	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PRKCA—melanoma	2.68e-05	0.000151	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ERCC2—melanoma	2.66e-05	0.00015	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLA2G6—melanoma	2.58e-05	0.000145	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CD—melanoma	2.55e-05	0.000144	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALB—melanoma	2.52e-05	0.000142	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—VCAN—melanoma	2.31e-05	0.000131	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CB—melanoma	2.22e-05	0.000125	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS2—melanoma	2.2e-05	0.000124	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CG—melanoma	2.1e-05	0.000118	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPARG—melanoma	2.03e-05	0.000114	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP17A1—melanoma	1.95e-05	0.00011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTEN—melanoma	1.92e-05	0.000108	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CD—melanoma	1.84e-05	0.000104	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GNA11—melanoma	1.84e-05	0.000104	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALB—melanoma	1.82e-05	0.000103	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FASN—melanoma	1.8e-05	0.000102	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A5—melanoma	1.77e-05	0.0001	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GNAQ—melanoma	1.71e-05	9.67e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CD44—melanoma	1.71e-05	9.67e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1B1—melanoma	1.64e-05	9.27e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CB—melanoma	1.61e-05	9.07e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS2—melanoma	1.59e-05	8.99e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTEN—melanoma	1.39e-05	7.84e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3CA—melanoma	1.36e-05	7.65e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCB1—melanoma	1.35e-05	7.64e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PRKCA—melanoma	1.25e-05	7.03e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ERCC2—melanoma	1.24e-05	6.97e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKT1—melanoma	1.11e-05	6.25e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3CA—melanoma	9.8e-06	5.53e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CG—melanoma	9.75e-06	5.5e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPARG—melanoma	9.41e-06	5.31e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CD—melanoma	8.58e-06	4.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALB—melanoma	8.47e-06	4.78e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKT1—melanoma	8.01e-06	4.52e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CB—melanoma	7.47e-06	4.22e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS2—melanoma	7.41e-06	4.18e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTEN—melanoma	6.46e-06	3.64e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3CA—melanoma	4.56e-06	2.57e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKT1—melanoma	3.72e-06	2.1e-05	CbGpPWpGaD
